Candel Therapeutics, Inc. (CADL)
6.20
-2.19
(-26.10%)
USD |
NASDAQ |
Nov 13, 16:00
6.05
-0.15
(-2.42%)
After-Hours: 19:59
Candel Therapeutics Price to Book Value : 3.696 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.696 |
| November 12, 2026 | 5.002 |
| November 11, 2026 | 5.496 |
| November 10, 2026 | 5.574 |
| November 09, 2026 | 5.657 |
| November 06, 2026 | 5.216 |
| November 05, 2026 | 4.793 |
| November 04, 2026 | 5.395 |
| November 03, 2026 | 5.258 |
| November 02, 2026 | 4.841 |
| October 30, 2026 | 4.966 |
| October 29, 2026 | 5.157 |
| October 28, 2026 | 5.168 |
| October 27, 2026 | 4.918 |
| October 26, 2026 | 4.644 |
| October 23, 2026 | 4.787 |
| October 22, 2026 | 4.996 |
| October 21, 2026 | 4.990 |
| October 20, 2026 | 5.151 |
| October 19, 2026 | 4.894 |
| October 16, 2026 | 4.882 |
| October 15, 2026 | 5.312 |
| October 14, 2026 | 5.407 |
| October 13, 2026 | 5.526 |
| October 12, 2026 | 5.830 |
| Date | Value |
|---|---|
| October 09, 2026 | 5.926 |
| October 08, 2026 | 5.759 |
| October 07, 2026 | 5.854 |
| October 06, 2026 | 5.884 |
| October 05, 2026 | 6.098 |
| October 02, 2026 | 6.069 |
| October 01, 2026 | 6.057 |
| September 30, 2026 | 6.224 |
| September 29, 2026 | 6.566 |
| September 28, 2026 | 6.753 |
| September 25, 2026 | 6.650 |
| September 24, 2026 | 6.970 |
| September 23, 2026 | 6.813 |
| September 22, 2026 | 7.151 |
| September 21, 2026 | 6.765 |
| September 18, 2026 | 6.548 |
| September 17, 2026 | 6.844 |
| September 16, 2026 | 6.650 |
| September 15, 2026 | 6.711 |
| September 14, 2026 | 6.442 |
| September 11, 2026 | 6.364 |
| September 10, 2026 | 6.838 |
| September 09, 2026 | 7.344 |
| September 08, 2026 | 7.604 |
| September 04, 2026 | 7.713 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Oragenics, Inc. | 0.8301 |
| Arcturus Therapeutics Holdings, Inc. | 1.410 |
| ACADIA Pharmaceuticals, Inc. | 2.335 |
| Alnylam Pharmaceuticals, Inc. | 6.131 |
| Anika Therapeutics, Inc. | 1.305 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0252 |
| Price | 6.20 |
| Earnings Yield | -23.98% |
| Market Cap | 471.93M |
| PEGY Ratio | -0.0252 |